<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001639'>Hypertrophic cardiomyopathy</z:hpo> phenotype is shared by <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> entities </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of the study was to evaluate the diagnostic role of left ventricular endomyocardial biopsy </plain></SENT>
<SENT sid="2" pm="."><plain>One hundred fifty-one consecutive patients with unexplained <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo> and <z:mpath ids='MPATH_458'>normal</z:mpath>/elevated QRS voltages or <z:hpo ids='HP_0011713'>left bundle-branch block</z:hpo> underwent left ventricular endomyocardial biopsy because of associated left ventricular dysfunction (37%), presence of <z:hpo ids='HP_0003745'>sporadic</z:hpo> form of <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo> (32%), or patient desire for a definite diagnosis (31%) </plain></SENT>
<SENT sid="3" pm="."><plain>Biopsy samples were processed for histology and electron microscopy </plain></SENT>
<SENT sid="4" pm="."><plain>Blood samples were collected for histologically oriented gene analysis of major sarcomeric (MYH7, MYBPC3, TNNT2, TPM1) and lysosomal (LAMP2, PRKAG2, α-galactosidase A) proteins </plain></SENT>
<SENT sid="5" pm="."><plain>Histology showed changes consistent/compatible with <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> in 124 patients: myocardial <z:e sem="disease" ids="C0267971" disease_type="Disease or Syndrome" abbrv="">storage disease</z:e> in 18 due to <z:e sem="disease" ids="C0002986" disease_type="Disease or Syndrome" abbrv="">Fabry disease</z:e> in 12 and <z:chebi fb="15" ids="28087">glycogen</z:chebi>-<z:e sem="disease" ids="C0267971" disease_type="Disease or Syndrome" abbrv="">storage disease</z:e> in 6 and myocardial infiltrative disease in 9 because of <z:hpo ids='HP_0011034'>amyloidosis</z:hpo> in 7 and <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> in 2 </plain></SENT>
<SENT sid="6" pm="."><plain>Gene analysis was positive in 67% of patients with <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> (MYH7 mutation in 36, MYBP in 29, TNNT2 in 14, and TPM1 in 5) and in 83% of patients with <z:e sem="disease" ids="C0085078" disease_type="Disease or Syndrome" abbrv="">lysosomal storage disease</z:e> (α-galactosidase A mutation in 12, PRKAG2 in 2, and LAMP2 in 1) </plain></SENT>
<SENT sid="7" pm="."><plain>In patients with <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> phenotype, left ventricular endomyocardial biopsy is safe and may recognize infiltrative/<z:e sem="disease" ids="C0267971" disease_type="Disease or Syndrome" abbrv="">storage diseases</z:e> in up to 18% of evolving and <z:hpo ids='HP_0003745'>sporadic</z:hpo> cases </plain></SENT>
</text></document>